Third Party Manufacturing

Nexkem is quality oriented company in India and have a product portfolio that covers all major therapy area, including Anti-Infective, Cardiology, Diabetology, Dermatology, Food-supplements, Gastrointestinal, Gynecology, Nutraceuticals, Neurology/Psychiatry, Orthopedics, Pulmonology, Pain Management and Urology.

Nexkem is using top class manufacturing facilities at Plot No 64, HPSIDC, Industrial Area Baddi, Solan (HP). Nexkem is all set to organize the upcoming challenges in the healthcare segment. The company asset has always been highly qualified and devoted workforce. In the organization all the departments are interlinked to each other with the latest co-ordination system to synchronize the administrative, planning, manufacturing, marketing and exporting process. Nexkem is achieving the goals with the support of its valuable associated business partners.

Nexkem is a manufacturer of formulations and we are recognizing in the market because of our ability to manufacture and supply various and qualitative range of Tablets, Capsules, Oral Liquid (Syrup & Suspension), Oral Dry Syrup, External Liquids, Ointments, Creams, Nutraceuticals, Oral Sachets/Powders, β-lactam products and Non β-lactam products.

To formulate our products we use hygienic ingredients that we have sourced from the authentic and reliable vendors of the market, who are certified and have rich expertise in that segment.

Send Enquiry

    innovation is always on

    Nexkem is always creating something new and affordable. This helps us to grow our business rapidly. While technology, knowledge and a desire to serve life sets us apart and drive us all to innovate.

    the aim of the Nexkem

    To achieve the satisfaction of our Customers in terms of:

  • To provide the quality products.
  • Orders delivery on the committed time.
  • Correct execution of our orders concerning: the conditions of the delivery speed of the execution of the contract.
  • To improve the level of service provided through constant communication with the Suppliers and providing all information as per our Customer’s requirements.
  • To make the company more flexible as per for our Customer’s expectations, avoiding defects and errors.
  • To improve the products portfolio and marketing approach by constant communication with the Marketing Team, Pharma Distributors, Pharma Chemists, Doctors and our entire Customer’s.
  • Nexkem have two separate buildings for β-lactam & Non β-lactam products.
  • For Non β-lactam product more than 20,000 sqft and for β-lactam products more than 15,000 sqft area has been constricted as per the WHO norms.
  • Quality Policy of Nexkem

    We at Nexkem are always committed to manufacture and supply superior products having high quality standards for healthier world.

    Nexkem quality focus encompasses all areas of its manufacturing operations – from procurement of raw materials, to best possible manufacturing technology, functional operations from on time delivery of formulations, to promotional help pushing its product to become a market brand.

    The Quality Assurance Department, managed by qualified persons, constantly examines quality considerations performing systematic sampling and testing at every stage from raw materials, through each procedure of intermediate and finished formulations. Vendor assessment and assortment is carried out as per stringent quality, product, manufacturing, service and delivery parameters to ensure the highest quality inputs.

    A regular validation of processes, test methods, water and environment, as well as periodic calibration of all instruments, to guarantee product output of consistent top quality formulations. A fully fledged Quality Control Laboratory at Nexkem’s manufacturing facility follows WHO-cGMP (current Good Manufacturing Practices) & GLP (Good Laboratory Practices) Compliance and integrates the most up to date testing equipments in order to perform the stringent quality analytical tests prescribed by different Pharmacopoeia.

    A separate Microbiology Laboratory with Class 10000 Cleanliness and a SS horizontal LAF (Laminar Air Flow) Unit. The full spectrum of formulations industry and sterility validation tests are conducted for on-going constant microbiological monitoring of all processes and products, as well as personnel and production areas, to ensure total product purity at our manufacturing facilities.

    Apart from following and maintaining an effective Quality Management System, Nexkem conducts periodic self-assessments through a voluntary self audit of its operations, in order to remain competitive in the formulations industry.

    The quality policy of Nexkem stands committed to Current Good Manufacturing Practices, conforming to International Standards, ensuring timely supply with cost effectiveness, quality products to meet customers' expectations, achieving high customer satisfaction and market leadership in domestic as well as overseas markets by implementing Quality Management Systems on continual improvement basis

    mission and vision

    Nexkem is a quality-driven manufacturing company always there to care and fortify the humanitarian approach of curing every unhealthy person on this earth.

    Nexkem has the only vision of providing international standard products at affordable cost for humanity. In India we have high diversity in all aspects, in the same way Nexkem reflects its Nationality with much diversified bucket of healing tools in the form of medicines to care.

    Nexkem believes its associates & business partners as a part of its vast mission to achieve the goal of healthy humanity.

    Nexkem

    Operation started in 2021.

    Located at Plot No 64, HPSIDC, Industrial Area Baddi, Solan (HP), this facility is well connected to rest of country by air, rail & road network. Nearest chandigarh international airport just 25km. from our factory.

    This facility is WHO-GMP approved. The manufacturing facility comprises of 15,000 sq.ft. of built-up area with the following product lines:

    Tablet Capsule Dry Powder This facility has an annual manufacturing capacity of 300 million tablets, 100 million capsules